MoonPay Partners With Injective To Boost Accessibility For DeFi Users

MoonPay has signed a partnership deal with the blockchain Injective to boost DeFi accessibility. Through these initiatives, MoonPay is steadily building its role as a key enabler of accessibility in the Web3 ecosystem.

More articles

Meghna Chowdhury
Meghna Chowdhury
Meghna is a Journalism graduate with specialisation in Print Journalism. She is currently pursuing a Master's Degree in journalism and mass communication. With over 3.5 years of experience in the Web3 and cryptocurrency space, she is working as a Senior Crypto Journalist for UnoCrypto. She is dedicated to delivering quality journalism and informative insights in her field. Apart from business and finance articles, horror is her favourite genre.

Payments platform MoonPay has signed a partnership deal with the blockchain Injective, which specializes in high-performance decentralized finance (DeFi) applications. Through this partnership, anyone can buy Injective’s native INJ token using a variety of payment options such as debit and credit cards, Apple Pay, Google Pay, PayPal, and even bank transfers. 

MoonPay Partners with Injective to Boost DeFi

In a blog post, MoonPay shared the news, describing the partnership as a significant step toward making DeFi more accessible to everyday users. Injective, founded in late 2018 and marketed as a “blockchain built for finance,” has quickly grown into an efficient, developer-friendly platform that supports various DeFi applications. 

The Injective ecosystem hosts multiple innovative decentralized applications (dApps), such as Helix, Mito, and Hydro Protocol. What sets Injective apart from other blockchains is its use of “modules”—pre-built components that developers can use to create new dApps quickly. 

This modular approach enables developers to launch powerful applications in days instead of the months typically required by traditional blockchains. “This partnership is particularly exciting because of Injective’s groundbreaking work in DeFi and its unique approach to building innovative financial products,” said Ivan Soto-Wright, co-founder and CEO of MoonPay. 

Injective co-founder and CEO Eric Chen added, “This means millions of MoonPay users will now be able to access INJ.” He noted that MoonPay’s wide range of payment options makes it easier for users to enter the Injective ecosystem and explore its dApps.

Why is the Partnership Important?

Injective also stands out for its cross-chain compatibility, which lets it connect with major blockchain networks such as Ethereum and Solana. Recently, Injective hit a milestone of one billion validated transactions, joining an exclusive group of blockchains to achieve this. 

Injective’s native crypto asset, the INJ token, has also experienced a major increase in market value. Currently trading at $24.93, INJ has risen by over 45% in the past week alone, bringing its global market cap to $2.45 billion.

Although its 24-hour trading volume saw a slight 4% dip, the token’s strong market performance signals continued investor interest and confidence.

MoonPay’s Other Partnerships This Year

This isn’t MoonPay’s first venture into DeFi and Web3. Earlier this year, MoonPay partnered with Polymarket to offer users a wider range of payment options. This partnership, which has been popular amid the rising interest in the U.S. presidential election, enables Polymarket users to fund their accounts through multiple payment methods. 

MoonPay’s Web3 marketing agency, Otherlife, has also provided strategic assistance to Polymarket, helping the platform reach a broader audience. Through these initiatives, MoonPay is steadily building its role as a key enabler of accessibility in the Web3 ecosystem

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest